Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers).
Mannucci
P M
PM
A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Department of Medicine and Medical Specialties, University of Milan, Italy. pmmannucci@libero.it
Gringeri
A
A
Peyvandi
F
F
Santagostino
E
E
D001779:Blood Coagulation Factors / Q000032:analysis / Q000627:therapeutic use*; D002675:Child, Preschool; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007223:Infant; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D018401:Sample Size
D001779:Blood Coagulation Factors; C078147:F8 protein, human; D005169:Factor VIII; C065655:anti-inhibitor coagulant complex